You just read:

NMT Pharmaceuticals Singapore Announces Signing of Licensing Agreement with CAO Pharmaceuticals USA on Anti-cancer Drug CZ-48 and Initiation of Phase I Study

News provided by

NMT Pharmaceuticals

11 Apr, 2016, 13:00 BST